Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

554 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Exploring the Multifaceted Nexus of Uric Acid and Health: A Review of Recent Studies on Diverse Diseases.
Kuwabara M, Fukuuchi T, Aoki Y, Mizuta E, Ouchi M, Kurajoh M, Maruhashi T, Tanaka A, Morikawa N, Nishimiya K, Akashi N, Tanaka Y, Otani N, Morita M, Miyata H, Takada T, Tsutani H, Ogino K, Ichida K, Hisatome I, Abe K. Kuwabara M, et al. Among authors: otani n. Biomolecules. 2023 Oct 13;13(10):1519. doi: 10.3390/biom13101519. Biomolecules. 2023. PMID: 37892201 Free PMC article. Review.
[Disturbance of uric acid metabolism].
Ouchi M, Otani N, Anzai N. Ouchi M, et al. Among authors: otani n. Nihon Jinzo Gakkai Shi. 2015;57(4):766-73. Nihon Jinzo Gakkai Shi. 2015. PMID: 26126334 Japanese. No abstract available.
Effects of Uric Acid on the NO Production of HUVECs and its Restoration by Urate Lowering Agents.
Mishima M, Hamada T, Maharani N, Ikeda N, Onohara T, Notsu T, Ninomiya H, Miyazaki S, Mizuta E, Sugihara S, Kato M, Ogino K, Kuwabara M, Hirota Y, Yoshida A, Otani N, Anzai N, Hisatome I. Mishima M, et al. Among authors: otani n. Drug Res (Stuttg). 2016 May;66(5):270-4. doi: 10.1055/s-0035-1569405. Epub 2016 Feb 24. Drug Res (Stuttg). 2016. PMID: 26909689
Uric acid lowering in relation to HbA1c reductions with the SGLT2 inhibitor tofogliflozin.
Ouchi M, Oba K, Kaku K, Suganami H, Yoshida A, Fukunaka Y, Jutabha P, Morita A, Otani N, Hayashi K, Fujita T, Suzuki T, Yasutake M, Anzai N. Ouchi M, et al. Among authors: otani n. Diabetes Obes Metab. 2018 Apr;20(4):1061-1065. doi: 10.1111/dom.13170. Epub 2018 Jan 8. Diabetes Obes Metab. 2018. PMID: 29171930 Free PMC article.
Protective Effects of Topiroxostat on an Ischemia-Reperfusion Model of Rat Hearts.
Tanno S, Yamamoto K, Kurata Y, Adachi M, Inoue Y, Otani N, Mishima M, Yamamoto Y, Kuwabara M, Ogino K, Miake J, Ninomiya H, Shirayoshi Y, Okada F, Yamamoto K, Hisatome I. Tanno S, et al. Among authors: otani n. Circ J. 2018 Mar 23;82(4):1101-1111. doi: 10.1253/circj.CJ-17-1049. Epub 2018 Feb 28. Circ J. 2018. PMID: 29491325 Free article.
Uric Acid-Induced Enhancements of Kv1.5 Protein Expression and Channel Activity via the Akt-HSF1-Hsp70 Pathway in HL-1 Atrial Myocytes.
Taufiq F, Maharani N, Li P, Kurata Y, Ikeda N, Kuwabara M, Otani N, Miake J, Hasegawa A, Tsuneto M, Shirayoshi Y, Ninomiya H, Saitoh T, Nakai A, Yamamoto K, Hisatome I. Taufiq F, et al. Among authors: otani n. Circ J. 2019 Mar 25;83(4):718-726. doi: 10.1253/circj.CJ-18-1088. Epub 2019 Feb 20. Circ J. 2019. PMID: 30787218 Free article.
Recent approaches to gout drug discovery: an update.
Otani N, Ouchi M, Kudo H, Tsuruoka S, Hisatome I, Anzai N. Otani N, et al. Expert Opin Drug Discov. 2020 Aug;15(8):943-954. doi: 10.1080/17460441.2020.1755251. Epub 2020 Apr 24. Expert Opin Drug Discov. 2020. PMID: 32329387 Review.
554 results